Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
SAB Biotherapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
04/05/2023 4 Lucera Erick (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.465, valued at $11.6k
03/16/2023 4 Kropotova Alexandra (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 275,000 shares @ $0
03/16/2023 4 Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 525,000 options to buy @ $0.54, valued at $283.5k
03/16/2023 4 Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 525,000 options to buy @ $0.54, valued at $283.5k
03/16/2023 4 Bausch Christoph Lawrence (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 275,000 options to buy @ $0.54, valued at $148.5k
03/16/2023 4 Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 275,000 options to buy @ $0.54, valued at $148.5k
03/02/2023 4 Spragens Jeffrey G (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Acquired 19,936 warrants @ $11.5, valued at $229.3k
03/02/2023 4 Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Disposed of 208,600 warrants @ $11.5, valued at $2.4M
Acquired 9,968 warrants @ $11.5, valued at $114.6k
12/09/2022 4 HAMILTON CHRISTINE E (10% Owner) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 82,987 shares @ $1.205, valued at $100k
Granted 82,987 options to buy @ $1.08, valued at $89.6k
12/09/2022 4 Spragens Jeffrey G (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 82,987 shares @ $1.205, valued at $100k
Granted 82,987 options to buy @ $1.08, valued at $89.6k
12/09/2022 4 Link David Charles (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 41,493 shares @ $1.205, valued at $50k
Granted 41,493 options to buy @ $1.08, valued at $44.8k
09/15/2022 4 Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 525,000 options to buy @ $0.71, valued at $372.8k
09/15/2022 4 Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 35,000 options to buy @ $0.71, valued at $24.9k
09/15/2022 4 Giberson Scott (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.71, valued at $17.8k
09/15/2022 4 Kropotova Alexandra (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 18,325 options to buy @ $0.71, valued at $13k
09/15/2022 4 Bausch Christoph Lawrence (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 274,875 options to buy @ $0.71, valued at $195.2k
09/15/2022 4 Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 274,875 options to buy @ $0.71, valued at $195.2k
09/14/2022 4 HAMILTON CHRISTINE E (10% Owner) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Bought 10,000 shares @ $0.7297, valued at $7.3k
09/08/2022 4 Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Bought 14,000 shares @ $0.7368, valued at $10.3k
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Disposed of 2,500,127 shares @ $0
Acquired 207,001 shares @ $0
03/18/2022 4 Sullivan Eddie Joe (CEO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 21,218 options to buy @ $1.78, valued at $37.8k
03/18/2022 4 Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 6,000 options to buy @ $1.78, valued at $10.7k
03/18/2022 4 Luke Thomas Charles (Chief Medical Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 20,519 options to buy @ $1.78, valued at $36.5k
03/18/2022 4 Finnegan Frederick (Chief Business Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 23,453 options to buy @ $1.78, valued at $41.7k
03/18/2022 4 Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 7,000 options to buy @ $1.78, valued at $12.5k
03/18/2022 4 Ullerich Melissa Vera (Chief Communications Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 16,405 options to buy @ $1.78, valued at $29.2k
03/18/2022 4 Pommer Jerry Lynn (Chief Compliance Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 15,172 options to buy @ $1.78, valued at $27k
03/18/2022 4 Bausch Christoph Lawrence (Chief Science Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 24,972 options to buy @ $1.78, valued at $44.5k
03/18/2022 4 Erickson Bruce Kipp (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 18,196 options to buy @ $1.78, valued at $32.4k
11/19/2021 4 Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 110,000 options to buy @ $11.17, valued at $1.2M
11/19/2021 4 Reich Samuel J (Executive Chairman) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 350,000 options to buy @ $11.17, valued at $3.9M
11/16/2021 4 Beyer Russell P (CFO) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 2,475 shares @ $10.1, valued at $25k
Granted 149 shares @ $10.08, valued at $1.5k
Granted 129 shares @ $7.78, valued at $1k
Sold 278 shares @ $7.9, valued at $2.2k
Granted 5 shares @ $10.07, valued at $50.4
Granted 10 shares @ $10.08, valued at $100.8
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy